Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization

被引:148
作者
Janes, KA [1 ]
Alonso, MJ [1 ]
机构
[1] Univ Santiago de Compostela, Sch Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela 15706, Spain
关键词
chitosan; molecular weight; nanoparticles; peptide; delivery; nasal delivery;
D O I
10.1002/app.12016
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In this article we describe our preliminary work involving the use of depolymerized, low molecular weight chitosan nanoparticles as carriers for proteins and peptides. We hypothesized that the molecular weight of chitosan could favorably modulate the particle and protein release characteristics for the delivery of certain bioactive macromolecules. Our primary objectives were to develop nanoparticle formulations that were stable and reproducible across a range of chitosan molecular weights and then characterize the physicochemical and in vitro release properties as functions of the polymer size. Using depolymerized fragments generated by NaNO2 degradation of different chitosan salts, we prepared nanoparticle formulations based on ionotropic gelation with sodium tripolyphosphate (TPP). Regardless of the formulation, the nanoparticle size decreased with decreasing molecular weight and the zeta-potential values remained unchanged. Similar comparisons were made with the encapsulation of insulin and tetanus toxoid as model proteins. The results indicated that the quantity of TPP in a given formulation has a greater effect on the protein encapsulation than the chitosan molecular weight. In fast release environments (i.e., buffered media), there was no significant molecular weight effect that could be discerned. These data lead to the conclusion that, under these experimental conditions, the chitosan molecular weight has a measurable effect on the particle properties, although this effect is modest relative to other formulation parameters (e.g., TPP content, type of protein loaded). Because these subtle differences could have dramatic effects physiologically, work is currently underway to elucidate the possible applications of depolymerized chitosans for peptide delivery in vivo. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:2769 / 2776
页数:8
相关论文
共 32 条
  • [1] [Anonymous], 1991, Advances in carbohydrate analysis
  • [2] SOLUTION PROPERTIES OF CHITOSANS - CONFORMATION AND CHAIN STIFFNESS OF CHITOSANS WITH DIFFERENT DEGREES OF N-ACETYLATION
    ANTHONSEN, MW
    VARUM, KM
    SMIDSROD, O
    [J]. CARBOHYDRATE POLYMERS, 1993, 22 (03) : 193 - 201
  • [3] HYDROGEN-ION TITRATION OF CHITOSANS WITH VARYING DEGREES OF N-ACETYLATION BY MONITORING INDUCED H-1-NMR CHEMICAL-SHIFTS
    ANTHONSEN, MW
    SMIDSROD, O
    [J]. CARBOHYDRATE POLYMERS, 1995, 26 (04) : 303 - 305
  • [4] EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2)
    ARTURSSON, P
    LINDMARK, T
    DAVIS, SS
    ILLUM, L
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (09) : 1358 - 1361
  • [5] Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs
    Berthold, A
    Cremer, K
    Kreuter, J
    [J]. JOURNAL OF CONTROLLED RELEASE, 1996, 39 (01) : 17 - 25
  • [6] The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
    Borchard, G
    Luessen, HL
    deBoer, AG
    Verhoef, JC
    Lehr, CM
    Junginger, HE
    [J]. JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) : 131 - 138
  • [7] Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
  • [8] 2-4
  • [9] Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
    Calvo, P
    RemunanLopez, C
    VilaJato, JL
    Alonso, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (10) : 1431 - 1436
  • [10] CALVO P, 1998, P WORLD M APGI APV, V2, P1111